XinXiang WeiDe Chemical Co.,Ltd have been founded in 2004, the existing registered capital of 30 million, is a new science-and-technology enterprise which in the integration of exploitation, development, production and sell. The mainly produces of company is pharmaceutical intermediates such as Acetic acid, 1,2,3,5-Tetra-O-Acetyl-D-Ribose, Cytosine, Hypoxanthine, N2,9-Diacetylguanine, basing sales on production. Company sufficient orders.
After more than ten years of development, the company has advanced research and development center, perfect quality control equipment and modern production lines. Also the company has a large number of technicist and management personnel who has more than middle and senior titles of a technical post. Our technology based on famous universities and research institutions such as Shanghai medical professionals, Xi An JiaoTong university, ZhengZhou university, HeNan academy of sciences and so on. The company is committed to offer high quality products to customers and partners and all-round services, with long-term stability of competitive products best-selling drug users at home and abroad, such as Europe countries, United States, India and South Korea.
By the lead of chairman Yang, XinXiang WeiDe Chemical Co.,Ltd adhering to the spirit of "people-oriented, pioneering and innovative, pursuit for excellence, healthy environmental protection, growing together, creating brilliant". The competitiveness of company has increased through scientific management and flattening management. Under the unremitting efforts of all members, the company has passed and obtained ISO9001:2008, ISO14001:2004 and OHSAS18001:2007 certification.
The company pays attention to environmental protection and social responsibility with the economic benefits increasing and used in the environmental protection facilities investment accounted for 15% of the company's total investment, and even increasing year by year. The waste water or gas after disposed is far lower than the national discharge standards. Make sure that the common development of enterprises and social benefits.
